NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
08/01/2023
Back to search
Official data from USPTO
EGENE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Quick snapshot
EGENE
ST13
US500000097132863Class
1, 5, 9, 10
Filing
97132863
Registration
7124080
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
23
Latest update
08/01/2023
Classification
Registered
Trademark type
Word
Nice classes
1, 5, 9, 10
Filing date
11/18/2021
Registration date
08/01/2023
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
08/01/2023
Last transaction
08/01/2023
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
99
Owner location
CAMBRIDGE, GB
Examiner
HARDY LUDLOW, TARAH KIM
Law office
M10
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
NUCLERA LTD
Nuclera Nucleics Limited
Representatives
Rebecca Liebowitz VENABLE LLP
Technical classification
Nice Classes
Class 1Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 1
Nucleic acids comprising natural and synthetic nucleotides and oligonucleotides for scientific and industrial purposes; synthetic DNAsynthetic RNAsynthetic genessynthetic oligonucleotides and synthetic proteins for scientific and industrial use; all for expression of proteins and none being mutation detection reagentsgenome editing reagentspolynucleotide assembly reagents
Class 5
Pharmaceutical and veterinary preparationsnucleic acids comprising natural and synthetic nucleotides and oligonucleotides for medical and veterinary purposes; synthetic DNAsynthetic RNAsynthetic genessynthetic oligonucleotidessynthetic proteins for clinical or medical use; DNA and RNA products for medical usenucleic acid sequencesgenes and proteins; therapeutic DNA and RNA productsnucleic acid sequencesgenes and proteins for medical and veterinary purposes; vaccines; all for expression of proteins and none being mutation detection reagentsgenome editing reagentspolynucleotide assembly reagents
Class 9
Scientific apparatus and instrumentsscientific desktop instruments for DNARNAgene and protein synthesis; scientific desktop instruments for DNARNAgene and protein synthesismicrofluidic devices; medical laboratory research instrument in the nature of desktop instrument cartridges for DNARNAgene and protein synthesisnamely microfluidic devices; semiconductors; semiconductor chips; microchips; bio sensors for scientificresearch or industrial purposes in DNARNAgene and protein synthesis; bio-chips for scientificresearch or industrial purposes; scientific research and laboratory apparatusapparatus and instruments for amplifying DNA and RNAreactorsbioreactorslaboratory apparatus and instruments for amplifying DNA and RNA using polymerase chain reaction (PCR); apparatus and instruments for synthesising DNA and RNAmicroarraysscientific desktop instrumentsdesktop instrument cartridgessemiconductorssemiconductor chipsmicrochipsbio sensorsbio-chips; scientific research and laboratory apparatusapparatus and instruments for processing DNA and RNAscientific desktop instrumentsdesktop instrument cartridgessemiconductorssemiconductor chipsmicrochipsbio sensorsbio-chips; computer hardwarerecorded computer softwaredownloadable computer softwaredownloadable bioinformatics software for use in DNARNAgene and protein synthesis in the fields of biotechnology and medical science
Class 10
Apparatus and instruments for DNARNAgene and protein synthesis for medical and veterinary purposes
Publications
History of USPTO decisions and trademark events.
23 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
08/01/2023
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/14/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/16/2023
PUBO
PUBLISHED FOR OPPOSITION
05/16/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
04/26/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
04/13/2023
XAEC
EXAMINER'S AMENDMENT ENTERED
04/13/2023
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
04/13/2023
GNEA
EXAMINERS AMENDMENT E-MAILED
04/13/2023
CNEA
EXAMINERS AMENDMENT -WRITTEN
04/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
04/11/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
04/11/2023
ALIE
ASSIGNED TO LIE
04/11/2023
AMPX
PRELIMINARY/VOLUNTARY AMENDMENT - ENTERED
03/30/2023
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
03/30/2023
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
02/27/2023
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/31/2022
GNRT
NON-FINAL ACTION E-MAILED
08/31/2022
CNRT
NON-FINAL ACTION WRITTEN
08/31/2022
DOCK
ASSIGNED TO EXAMINER
08/30/2022
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/23/2021
NWAP
NEW APPLICATION ENTERED
11/22/2021
Continuous trademark protection
Get notified about every new filing that threatens EGENE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.